| Univariate logistic regression | Multivariate logistic regression | |||
---|---|---|---|---|---|
Odds ratio (95% confidence interval) | P-value | Odds ratio (95% confidence interval) | P-value | ||
Age | 1.02 (1.01–1.04) | 0.010 | 1.01 (0.98–1.04) | 0.698 | |
Gender | 0.79 (0.46–1.38) | 0.415 |  |  | |
Duration of ICS use | 1.06 (1.01–1.13) | 0.031 | 0.95 (0.85–1.05) | 0.287 | |
Duration of asthma | Â | Â | Â | Â | |
> 10 years | 3.03 (1.64–5.61) | 0.000 | 3.07 (1.04–9.05) | 0.042 | |
FEV1% predicted | 0.98 (0.97–0.99) | 0.009 | 1.00 (0.98–1.02) | 0.831 | |
BIP-1 Consequences | 1.38 (1.22–1.56) | 0.000 | 1.17 (0.95–1.45) | 0.135 | |
BIP-2 Timeline | 1.04 (0.95–1.13) | 0.449 |  |  | |
BIP-3 Personal control | 0.77 (0.67–0.87) | 0.000 | 0.75 (0.62–0.90) | 0.003 | |
BIP-4 Treatment control | 0.91 (0.80–1.03) | 0.128 |  |  | |
BIP-5 Identity | 1.36 (1.21–1.53) | 0.000 | 1.05 (0.86–1.29) | 0.620 | |
BIP-6 Concerns | 1.04 (0.91–1.20) | 0.533 |  |  | |
BIP-7 Comprehension | 0.98 (0.88–1.08) | 0.670 |  |  | |
BIP-8 Emotional response | 1.17 (1.06–1.29) | 0.002 | 1.15 (0.97–1.36) | 0.105 | |
Medication adherence | 0.65 (0.50–0.84) | 0.001 | 0.59 (0.40–0.88) | 0.009 |